Fear over the recent coronavirus outbreak continues to manifest in extreme ways. Retail stores have run out of hand sanitizers; the stock market has plunged, and healthcare institutions are overwhelmed.
China has become the most popular region for clinical trial research over the last few years. A recent case study showed clinical trials had increased by 451% between years 2010 and 2017. This increasing investment by large companies like BeiGene, Ltd. is a result of the continuing effort by Chinese regulators to improve healthcare facilities to compete on a global scope.
We are living in unprecedented times. On the 11th of March 2020, the world health organization upgraded the COVID-19 epidemic as a pandemic and different countries have implemented different ways to tackle the spread of this disease. Much of this involves social distancing especially for the vulnerable in our societies.